6Lavanchy D. World Health Organization, 50 years of influenza surveillance: a challenge for the 21st century: meeting 17-19 February 1999, WHO, Geneva, Vaccine, 2002, 20(suppl 2) :s1-s4. 被引量：1
7Nerome R, Nerome K, Tanabe N, et al. Perspectives on the characteristics and achievements of recent surveillance of influenza activity in Japan. Vaccine, 2002, 20(suppl 2) :s36-s43. 被引量：1
8Shaw MW, Xu X, Li Y, et al. Reappearance and global spread of variants of influenza B/Victoria/2/87 lineage viruses in the 2000-2001 and 2001-2002 seasons. Virology, 2002,303 : 1-8. 被引量：1
9Jonathan S,Nguyen-Vantam, Hampson AW. The epidemiology and clinical impact of pandemic influenza. Vaccine, 2003, 21 : 1762-1768. 被引量：1
10Klaus Stohr. The global agenda on influenza surveillance and control.Vaccine, 2003, 21 : 1744-1748. 被引量：1
